Boxer Michael A's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Feb 8, 2024
- Accession no.
- 0001127602-24-004033
- Filed
- Feb 8, 2024
- Trade date
- Feb 7, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $8.19M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boxer Michael ACIK 0001726596 | Officer (SVP and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2024 | Common Stock | MOption exerciseAcquired | +14,566 | $192.98 | +$2,810,946.68 | 27,467.06 | Direct | |
| Feb 7, 2024 | Common Stock | SSaleDisposed | −14,566 | $562.00 | −$8,186,092 | 12,901.06 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2024 | Common Stock | MOption exerciseDisposed | −14,566 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.